Shehnaaz Suliman

(Shehnaaz Suliman)

Currently holds positions in Ultragenyx Pharmaceutical Inc and Alector Inc

Positions
Position Company Period
Independent Director Ultragenyx Pharmaceutical Inc Jan. 30, 2019 -
President, Chief Operating Officer Alector Inc Dec. 11, 2019 -
Senior Vice President - Corporate Development and Strategy Theravance Biopharma Inc July 31, 2017 - Dec. 31, 2019
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-12-14 2021-12-13
US Alector Inc (ALEC)
PS Planned sale
10,898 -9.6%
21.73
236,802 USD 		10,898 -9.6% 21.73 236,802 USD
2021-12-14 2021-12-13
US Alector Inc (ALEC)
PS Planned sale
64,102 -36.1%
21.16
1,356,347 USD 		64,102 -36.1% 21.16 1,356,347 USD
2021-12-14 2021-12-10
US Alector Inc (ALEC)
PS Planned sale
8,874 -8.0%
22.33
198,192 USD 		8,874 -8.0% 22.33 198,192 USD
2021-12-14 2021-12-10
US Alector Inc (ALEC)
PS Planned sale
66,126 -37.2%
21.69
1,433,975 USD 		66,126 -37.2% 21.69 1,433,975 USD
2021-12-10 2021-12-09
US Alector Inc (ALEC)
PS Planned sale
2,643 -2.5%
23.40
61,858 USD 		2,643 -2.5% 23.40 61,858 USD
2021-12-10 2021-12-09
US Alector Inc (ALEC)
PS Planned sale
72,357 -40.7%
22.80
1,649,986 USD 		72,357 -40.7% 22.80 1,649,986 USD
2021-12-10 2021-12-08
US Alector Inc (ALEC)
PS Planned sale
38,489 -27.3%
23.01
885,690 USD 		38,489 -27.3% 23.01 885,690 USD
2021-12-10 2021-12-08
US Alector Inc (ALEC)
PS Planned sale
36,511 -20.6%
22.56
823,626 USD 		36,511 -20.6% 22.56 823,626 USD